This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Das, S. Articles by Pastan, I. Search for Related Content PubMed PubMed Citation Articles by Das, S. Articles by Pastan, I.

Topology of NGEP, a Prostate-Specific Cell:Cell Junction Protein Widely Expressed in Many Cancers of Different Grade Level

¹ Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland; ² Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina; and ³ Department of Urology, Stanford University School of Medicine, Stanford, California

Requests for reprints: Ira Pastan, Laboratory of Molecular Biology, National Cancer Institute, 37 Convent Drive, Room 5106, Bethesda, MD 20892-4264. Phone: 301-496-4797; Fax: 301-402-1344; E-mail: pastani{at}mail.nih.gov.

Key Words: prostate cancer • immunotherapy • plasma membrane protein • TMEM16E • N-glycosylation

New gene expressed in prostate (NGEP) is a prostate-specific polytopic membrane protein found at high concentrations at cell:cell contact regions. To determine if NGEP is a useful target for antibody-based therapy of prostate cancer, we performed an immunohistochemical analysis of 126 human prostate carcinoma samples using polyclonal anti-NGEP sera and found that 91% of the cancers express NGEP protein. To elucidate the topology of NGEP and guide the development of monoclonal antibodies (mAb) reacting with the extracellular regions of NGEP, a hemagglutinin epitope tag was inserted at several positions within the NGEP sequence. The tagged proteins were expressed in 293T cells and locations of the tags were determined by immunofluorescence in intact or permeabilized cells. The results indicate that NGEP contains eight transmembrane domains with both the NH₂ and COOH termini of NGEP located inside the cell. We produced mAb to three regions that are predicted to be intracellular based on the epitope tag data (amino acids 1-352, 441-501, and 868-933), and as predicted, the mAb only detected the protein in permeabilized cells. NGEP is a glycoprotein with predicted glycosylation sites at N809 and N824. When these residues were converted to glutamine, glycosylation was abolished, confirming that the residues are extracellular. Our findings on the expression and the orientation of the NGEP protein serve as an important framework for the development of mAb targeting the extracellular regions of NGEP that could be used for prostate cancer immunotherapy. [Cancer Res 2008;68(15):6306–12]

This article has been cited by other articles:

				H. C. Hartzell, K. Yu, Q. Xiao, L.-T. Chien, and Z. Qu Anoctamin/TMEM16 family members are Ca2+-activated Cl\#8722; channels J. Physiol., May 1, 2009; 587(10): 2127 - 2139. [Abstract] [Full Text] [PDF]

				J. Yu, N. Sheung, E. M. Soliman, C. Spirli, and J. A. Dranoff Transcriptional regulation of IL-6 in bile duct epithelia by extracellular ATP Am J Physiol Gastrointest Liver Physiol, March 1, 2009; 296(3): G563 - G571. [Abstract] [Full Text] [PDF]